New heart valve device tested in small study
NCT ID NCT07601269
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This early-stage study tests a new device called the ReValve system to replace the mitral valve in people with a leaky valve. About 25 participants with moderate to severe symptoms will be enrolled. The main goal is to see if the device can be safely delivered and placed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL VALVE REPLACEMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute Dante Pazzanese of Cardiology - IDPC
RECRUITINGSão Paulo, São Paulo, SP, 04012-909, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Heart Institute - INCOR
RECRUITINGSão Paulo, São Paulo, SP, 05403-900, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.